CLINICAL_TRIALS
research
· 2019-01-30
Clinical Trial Update: Evaluation of Cerebral Small Vessel Disease in Patient With Primary Aldosteronism [Phase 1]
Summary
Phase 1 clinical trial evaluating cerebral small vessel disease in a patient with primary aldosteronism; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Taiwan University Hospital | Conditions: Evaluation of Cerebral Small Vessel Disease in Patient With Primary Aldosteronism | Phase 1 | Status: UNKNOWN